Skip to main content

Posts

Showing posts with the label medication adherence

6 Tips for proper COPD medication adherence

8 Tips for proper COPD medication adherence Taking your medication on time, at the right times, throughout the day will benefit you more than taking them at random when ever you remember to take them. Some people really struggle to remember how to take them as advised, and of course, to even bother taking them at all. I cannot tell you how many times I have forgotten to take them until it was almost bedtime!  Here are my top 6 tips on how to take your medications properly, and on time. Write the directions down on a piece of paper in the order that your doctor recommends you take them. You can also type them out on your computer using a font that appeals to use and enlarge them to fit 1 sheet of paper. Print that paper and put it in a plastic sheet protector . No matter how you do this, keep the list in the place you spend the most time in your home. Maybe that is the kitchen, on the end table next to your favorite chair in the living room, in the wall in the bath...

NEW ASTHMA TREATMENT AVAILABLE IN CLINICAL TRIAL

Because I joined CureClick, as a Clinical Trial Ambassador, you will see posts like this from me occasionally. Not all will be COPD related. Many COPD patients, like myself, suffer from other illness as well. So, this is in effort to aid in bringing awareness to Clinical Trials, and support the many other illnesses my family has had to deal with. With support, participation, and sharing, we can help find new treatments, or even a CURE for some illnesses! As always, I thank you for your continued support! NEW ASTHMA TREATMENT AVAILABLE IN CLINICAL TRIAL If you have  Mild or Moderate Asthma  and you're looking for new treatment options, this clinical trial may be right for you. This study is for patients who have mild or moderate asthma and are using a reliever inhaler. If approved, it is hoped that the study drug will improve your lung function and overall symptoms of asthma. More about the study: The study drug (Lebrikizumab ) is administered by Subcutaneous...